{"id":"https://openalex.org/W4392684665","doi":"https://doi.org/10.1158/0008-5472.c.6502956","title":"Data from Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T\u03b2RI/II Kinase Inhibition with LY2109761","display_name":"Data from Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T\u03b2RI/II Kinase Inhibition with LY2109761","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4392684665","doi":"https://doi.org/10.1158/0008-5472.c.6502956"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6502956","doi":"https://doi.org/10.1158/0008-5472.c.6502956","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6502956","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6502956","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003217224","display_name":"Erin C. Connolly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erin C. Connolly","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076488025","display_name":"Elise F. Saunier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elise F. Saunier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045090842","display_name":"David Alan Quigley","orcid":"https://orcid.org/0000-0002-4726-1473","observed_orcids":["https://orcid.org/0000-0002-4726-1473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Quigley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044559689","display_name":"Minh Thu Luu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minh Thu Luu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011141635","display_name":"Angela De Sapio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela De Sapio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016251331","display_name":"Byron C. Hann","orcid":"https://orcid.org/0000-0002-0715-5166","observed_orcids":["https://orcid.org/0000-0002-0715-5166"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Byron Hann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040117012","display_name":"Jonathan M. Yingling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan M. Yingling","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004545089","display_name":"Rosemary J. Akhurst","orcid":"https://orcid.org/0000-0002-4474-9668","observed_orcids":["https://orcid.org/0000-0002-4474-9668"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosemary J. Akhurst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13437","display_name":"Mechanisms of cancer metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ly2109761","display_name":"LY2109761","score":0.9710000157356262},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8859999775886536},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.7559999823570251},{"id":"https://openalex.org/keywords/7-12-dimethylbenz-a-anthracene","display_name":"7,12-dimethylbenz(a)anthracene","score":0.9169999957084656},{"id":"https://openalex.org/keywords/phorbol-myristate-acetate","display_name":"phorbol myristate acetate","score":0.8960000276565552},{"id":"https://openalex.org/keywords/tumor-vascular-architecture","display_name":"tumor vascular architecture","score":0.5979999899864197},{"id":"https://openalex.org/keywords/myofibroblast-differentiation","display_name":"myofibroblast differentiation","score":0.9480000138282776},{"id":"https://openalex.org/keywords/smad2-phosphorylation","display_name":"Smad2 phosphorylation","score":0.8730000257492065},{"id":"https://openalex.org/keywords/tumor-aggressiveness","display_name":"tumor aggressiveness","score":0.6179999709129333},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.8389999866485596},{"id":"https://openalex.org/keywords/il23a","display_name":"IL23A","score":0.7760000228881836},{"id":"https://openalex.org/keywords/matrix-metalloproteinases","display_name":"matrix metalloproteinases","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C2779448149","wikidata":"https://www.wikidata.org/wiki/Q191797","display_name":"Aggression","level":2,"score":0.5260750651359558},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.5152583122253418},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5083357691764832},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4749103784561157},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4178571403026581},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3580982983112335},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25102895498275757},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22311660647392273},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1686708927154541},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0647512674331665},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.06078481674194336},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6502956","doi":"https://doi.org/10.1158/0008-5472.c.6502956","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6502956","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6502956","doi":"https://doi.org/10.1158/0008-5472.c.6502956","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6502956","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1986304685","https://openalex.org/W3114521543","https://openalex.org/W1518628133","https://openalex.org/W2165487575","https://openalex.org/W1974203539","https://openalex.org/W2578524818","https://openalex.org/W2991693123","https://openalex.org/W2225574504","https://openalex.org/W1990842005","https://openalex.org/W7095206635"],"abstract_inverted_index":{"Abstract":[0],"TGF-\u03b2":[1,23,45,228],"is":[2,190],"produced":[3],"excessively":[4],"by":[5,160],"many":[6],"solid":[7],"tumors":[8],"and":[9,21,58,78,125,132,166,210,217,224],"can":[10],"drive":[11],"malignant":[12],"progression":[13],"through":[14],"multiple":[15],"effects":[16],"on":[17,149],"the":[18,39,59,92,128,142,175,191,202],"tumor":[19,55,75,89,143],"cell":[20],"microenvironment.":[22],"signaling":[24],"pathway":[25],"inhibitors":[26,229],"have":[27],"shown":[28],"efficacy":[29],"in":[30,52,69,87,212],"preclinical":[31],"models":[32],"of":[33,41,63,82,104,130,157,177,194,201,220],"metastatic":[34],"cancer.":[35],"Here,":[36],"we":[37],"investigated":[38],"effect":[40,148],"systemic":[42],"LY2109761,":[43],"a":[44,54,88,198],"type":[46],"I/II":[47],"receptor":[48],"(T\u03b2RI/T\u03b2RII)":[49],"kinase":[50],"inhibitor,":[51],"both":[53],"allograft":[56],"model":[57,62],"mouse":[60],"skin":[61,84,98],"de":[64],"novo":[65],"chemically":[66],"induced":[67],"carcinogenesis":[68,100],"vivo.":[70],"Systemic":[71],"LY2109761":[72,110,138,171],"administration":[73],"disrupted":[74],"vascular":[76],"architecture":[77],"reduced":[79],"myofibroblast":[80],"differentiation":[81],"E4":[83],"carcinoma":[85,150],"cells":[86],"allograft.":[90],"In":[91],"7,12-dimethyl-benzanthracene":[93],"plus":[94],"phorbol":[95],"myristate":[96],"acetate\u2013induced":[97],"chemical":[99],"model,":[101],"acute":[102,237],"dosing":[103],"established":[105],"naive":[106],"primary":[107],"carcinomas":[108,159,178,206],"with":[109,179,214,249],"(100":[111,119,139],"mg/kg)":[112,120],"every":[113],"8":[114],"hours":[115],"for":[116,234],"10":[117],"days":[118],"diminished":[121],"phospho-Smad2":[122],"(P-Smad2)":[123],"levels":[124,182],"marginally":[126],"decreased":[127],"expression":[129,219],"inflammatory":[131,211],"invasive":[133],"markers.":[134],"Sustained":[135],"exposure":[136,172,242],"to":[137,174,187,197,243],"mg/kg/d)":[140],"throughout":[141],"outgrowth":[144,176],"phase":[145],"had":[146],"no":[147],"latency":[151],"or":[152],"incidence.":[153],"However,":[154],"molecular":[155],"analysis":[156],"resultant":[158],"microarray":[161],"gene":[162],"expression,":[163],"Western":[164],"blotting,":[165],"immunohistochemistry":[167],"suggests":[168],"that":[169,183],"long-term":[170,240],"leads":[173],"elevated":[180,218],"P-Smad2":[181],"do":[184],"not":[185],"respond":[186],"drug.":[188],"This":[189],"first":[192],"description":[193],"acquired":[195],"resistance":[196],"small-molecule":[199],"inhibitor":[200],"T\u03b2RI/T\u03b2RII":[203],"kinase.":[204],"Resultant":[205],"were":[207],"more":[208],"aggressive":[209],"nature,":[213],"delocalized":[215],"E-cadherin":[216],"Il23a,":[221],"laminin":[222],"V,":[223],"matrix":[225],"metalloproteinases.":[226],"Therefore,":[227],"might":[230],"be":[231,247],"clinically":[232],"useful":[233],"applications":[235],"requiring":[236],"administration,":[238],"but":[239],"patient":[241],"such":[244],"drugs":[245],"should":[246],"undertaken":[248],"caution.":[250],"Cancer":[251],"Res;":[252],"71(6);":[253],"2339\u201349.":[254],"\u00a92011":[255],"AACR.":[256]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-03-13T00:00:00"}